Roflumilast Cream 0.05%
ARQ-151-315
Phase 3 small_molecule completed
Quick answer
Roflumilast Cream 0.05% for Atopic Dermatitis Eczema is a Phase 3 program (small_molecule) at Arcutis Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcutis Biotherapeutics
- Indication
- Atopic Dermatitis Eczema
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed